Urology News and Research

Latest Urology News and Research

VTE patients tend to die earlier from bladder cancer

In a study of 3879 patients who underwent radical cystectomy to treat bladder cancer, 3.6% were diagnosed with a venous thromboembolism (VTE)—which occurs when a blood clot forms in a vein, potentially breaking loose and traveling to the lung—within 1 month of their surgical admission date.

8 Mar 2016

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

A study of obesity and related metabolic changes on bladder cancer incidence and deaths, and a plan to use stem cells to grow novel urinary tubes are among 10 research projects awarded funding by the Johns Hopkins Greenberg Bladder Cancer Institute.

7 Mar 2016

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

The U.S. Food and Drug Administration has approved IMBRUVICA (ibrutinib) capsules for treatment-naïve patients with chronic lymphocytic leukemia (CLL).

4 Mar 2016

New study finds link between vitamin D deficiency and aggressive prostate cancer

A new study provides a major link between low levels of vitamin D and aggressive prostate cancer. Northwestern Medicine research showed deficient vitamin D blood levels in men can predict aggressive prostate cancer identified at the time of surgery.

2 Mar 2016

Researchers develop new method to screen tumor samples for presence of human polyomaviruses

Human polyomaviruses are commonly found in the population and generally do not produce noticeable symptoms. However, one type of human polyomavirus, the Merkel cell polyomavirus, is known to cause a rare form of skin cancer called Merkel cell carcinoma, and other members of the polyomavirus family can induce non-cancer related diseases in people with compromised immune systems.

27 Feb 2016

Light reflectance spectroscopy may lead to real-time tissue analysis during prostate cancer surgery

Researchers at UT Southwestern Medical Center have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that may lead to real-time tissue analysis during prostate cancer surgery.

27 Feb 2016

Black men have higher rate and probability of PSA screening compared to non-Hispanic whites

African American men have the highest rate of prostate cancer and shorter survival time compared to other racial/ethnic groups in the U.S. Their mortality rate is more than twice that of their white counterparts. Early diagnosis through PSA screening may help forestall consequent morbidity and mortality.

26 Feb 2016

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older.

26 Feb 2016

Pancreatic cancer identified as four separate diseases with different genetic triggers, survival rates

An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.

25 Feb 2016

Study examines long-term impact of delivery mode on stress urinary incontinence

Stress and urgency incontinence are the two most frequent and the most bothersome urinary symptoms among women. It has been estimated that about twelve percent of women report significant bother from stress incontinence and eight percent from urgency incontinence. Urinary incontinence affects hundreds of millions of women worldwide.

24 Feb 2016

New article describes recent efforts made by researchers to classify bladder cancers

The ability to map the human genome has transformed how scientists and researchers classify various cancers. In the past, cancer cells were examined through a microscope and their appearance, often enhanced with dyes or other agents, was used to categorize the type of cancer.

22 Feb 2016

Physical therapy reduces urinary problems in postmenopausal women with osteoporosis

After menopause, women with osteoporosis struggle more with urinary incontinence than women with healthy bones do. But physical therapy that includes pelvic floor muscle training can produce dramatic improvements, shows a study published online today in Menopause, the journal of The North American Menopause Society.

17 Feb 2016

Older people undergoing cancer surgery more likely to experience injuries, health issues

Older people who undergo cancer surgery are more likely than their younger counterparts to experience injuries and health issues such as falling down, breaking bones, dehydration, bed sores, failure to thrive and delirium. These age-related issues may lead to longer hospital stays, increased health care costs and a greater risk of death, a UCLA study found.

17 Feb 2016

Aytu BioScience announces business strategy update and Q2 financial results

Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions, provided today an overview of its business and growth strategy, as well as its financial results for the quarter ended December 31, 2015.

17 Feb 2016

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

16 Feb 2016

Sonablate HIFU now available in southern California for treatment of prostate cancer patients

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using high intensity focused ultrasound, announces that Sonablate HIFU is now available in southern California through a partnership established with Western States HIFU and Pacific Coast Urology and one of the most experienced HIFU physicians in the world, Robert Pugach, MD.

16 Feb 2016

Philadelphia jury returned $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary

Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Philadelphia jury returned a $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary on Wednesday, making this the second substantial verdict award in favor of the plaintiffs in recent months.

12 Feb 2016

Liverpool researchers reach major milestone towards creating diagnostic test for prostate cancer

A research team from the University of Liverpool has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.

12 Feb 2016

Vanderbilt physicians examine risk factors for cardiovascular disease in prostate cancer survivors

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease's slow progression.

11 Feb 2016

Scientists propose use of mathematical models to find better treatment for bladder cancer

MIPT scientists together with their colleagues from St. Petersburg and Israel have analyzed more than 500 previously published scientific articles and proposed their own approach to the choice of methods used for the treatment of one of the most common cancers.

11 Feb 2016

Urology News and Research

Latest Urology News and Research

VTE patients tend to die earlier from bladder cancer

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

New study finds link between vitamin D deficiency and aggressive prostate cancer

Researchers develop new method to screen tumor samples for presence of human polyomaviruses

Light reflectance spectroscopy may lead to real-time tissue analysis during prostate cancer surgery

Black men have higher rate and probability of PSA screening compared to non-Hispanic whites

Allergan receives FDA approval to market ACZONE (dapsone) Gel, 7.5% for acne treatment

Pancreatic cancer identified as four separate diseases with different genetic triggers, survival rates

Study examines long-term impact of delivery mode on stress urinary incontinence

New article describes recent efforts made by researchers to classify bladder cancers

Physical therapy reduces urinary problems in postmenopausal women with osteoporosis

Older people undergoing cancer surgery more likely to experience injuries, health issues

Aytu BioScience announces business strategy update and Q2 financial results

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Sonablate HIFU now available in southern California for treatment of prostate cancer patients

Philadelphia jury returned $13.5 million verdict against Johnson & Johnson's Ethicon subsidiary

Liverpool researchers reach major milestone towards creating diagnostic test for prostate cancer

Vanderbilt physicians examine risk factors for cardiovascular disease in prostate cancer survivors

Scientists propose use of mathematical models to find better treatment for bladder cancer

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Urology News and Research

Latest Urology News and Research

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in